• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者外周免疫细胞中白细胞介素 1 受体和巨噬细胞清道夫受体 I 的表面水平分析。

Analysis of Surface Levels of IL-1 Receptors and Macrophage Scavenger Receptor I in Peripheral Immune Cells of Patients With Alzheimer Disease.

机构信息

1 Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.

2 Department of Medicine III, Institute for Clinical Immunology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.

出版信息

J Geriatr Psychiatry Neurol. 2019 Jul;32(4):211-220. doi: 10.1177/0891988719841728. Epub 2019 Apr 24.

DOI:10.1177/0891988719841728
PMID:31018751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6552296/
Abstract

Increased concentrations of interleukin 1 (IL-1) in the cerebrospinal fluid and serum of patients with Alzheimer disease (AD) reduced phagocytic capacity point to an inflammatory activation of mononuclear phagocytes in AD. Interleukin 1 receptors (IL-1R) and the macrophage scavenger receptor I (MSRI) are important players in IL-1 signaling and phagocytosis. In 20 patients with AD and 17 controls, IL-1RI, IL-1RII, and MSRI were assessed on peripheral blood mononuclear cells by flow cytometry. IL-1β, soluble IL-1 receptors, and IL-1R antagonist (IL-1Ra) were measured by enzyme-linked immunosorbent assay. The fraction of IL-1RI+ monocytes was increased by 10% and the expression of MSRI was reduced by 12% in AD. A 3.6% increased fraction of IL-1RI+ lymphocytes was accompanied by a 6.1% reduced expression of IL-1RII. The IL-1RI on monocytes and lymphocytes discriminated patients with AD with an accuracy of 0.79 and 0.75, respectively. The IL-1Ra was elevated in AD. Changes in the expression of IL-1 receptors and MSRI on peripheral blood cells fit to the concept of a proinflammatory state of the peripheral immune system. However, the observed differences are not strong enough to suggest their application as biomarkers for AD.

摘要

阿尔茨海默病(AD)患者脑脊液和血清中白细胞介素 1(IL-1)浓度升高,吞噬能力降低,表明 AD 中单核吞噬细胞发生炎症激活。白细胞介素 1 受体(IL-1R)和巨噬细胞清道夫受体 I(MSRI)是 IL-1 信号转导和吞噬作用的重要参与者。在 20 名 AD 患者和 17 名对照者中,通过流式细胞术评估外周血单个核细胞上的 IL-1RI、IL-1RII 和 MSRI。通过酶联免疫吸附试验测量 IL-1β、可溶性 IL-1 受体和 IL-1R 拮抗剂(IL-1Ra)。AD 中单核细胞的 IL-1RI+比例增加了 10%,MSRI 的表达降低了 12%。IL-1RI+淋巴细胞的比例增加了 3.6%,IL-1RII 的表达降低了 6.1%。单核细胞和淋巴细胞上的 IL-1RI 可分别以 0.79 和 0.75 的准确度区分 AD 患者。AD 中 IL-1Ra 升高。外周血细胞上 IL-1 受体和 MSRI 表达的变化符合外周免疫系统促炎状态的概念。然而,观察到的差异不够强,不足以表明它们可作为 AD 的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae6a/6552296/c609c0656fa3/10.1177_0891988719841728-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae6a/6552296/5e94be812d2d/10.1177_0891988719841728-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae6a/6552296/9d7f400a1aa8/10.1177_0891988719841728-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae6a/6552296/4161bd30be3d/10.1177_0891988719841728-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae6a/6552296/c609c0656fa3/10.1177_0891988719841728-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae6a/6552296/5e94be812d2d/10.1177_0891988719841728-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae6a/6552296/9d7f400a1aa8/10.1177_0891988719841728-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae6a/6552296/4161bd30be3d/10.1177_0891988719841728-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae6a/6552296/c609c0656fa3/10.1177_0891988719841728-fig4.jpg

相似文献

1
Analysis of Surface Levels of IL-1 Receptors and Macrophage Scavenger Receptor I in Peripheral Immune Cells of Patients With Alzheimer Disease.阿尔茨海默病患者外周免疫细胞中白细胞介素 1 受体和巨噬细胞清道夫受体 I 的表面水平分析。
J Geriatr Psychiatry Neurol. 2019 Jul;32(4):211-220. doi: 10.1177/0891988719841728. Epub 2019 Apr 24.
2
Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.可溶性白细胞介素-1受体与白细胞介素-1α、白细胞介素-1β及白细胞介素-1受体拮抗剂的结合以及滑液中可溶性白细胞介素-1受体的水平
J Immunol. 1994 Nov 15;153(10):4766-74.
3
Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.前列腺癌中的白细胞介素-1(IL-1α和IL-1β)及其受体(IL-1RI、IL-1RII和IL-1Ra)
Cancer. 2004 Apr 1;100(7):1388-96. doi: 10.1002/cncr.20142.
4
Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo.脂多糖(LPS)对体外和体内单核吞噬细胞中白细胞介素-1受体家族成员表达的不同影响。
Cytokine. 1998 Oct;10(10):773-80. doi: 10.1006/cyto.1998.0359.
5
Extracellular regulation of interleukin (IL)-1beta through lung epithelial cells and defective IL-1 type II receptor expression.通过肺上皮细胞对白介素(IL)-1β进行细胞外调节以及白介素-1 II型受体表达缺陷
Am J Respir Cell Mol Biol. 1999 May;20(5):964-75. doi: 10.1165/ajrcmb.20.5.3458.
6
Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.慢性关节炎患者中可溶性白细胞介素-1Ⅱ型受体和白细胞介素-1受体拮抗剂水平升高:与炎症和关节破坏标志物的相关性
Arthritis Rheum. 1998 Jun;41(6):1083-9. doi: 10.1002/1529-0131(199806)41:6<1083::AID-ART15>3.0.CO;2-9.
7
IL-1 receptor-type expression in relation to atopy.与特应性相关的白细胞介素-1受体类型表达
J Allergy Clin Immunol. 1999 Jun;103(6):1100-7. doi: 10.1016/s0091-6749(99)70185-5.
8
Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I.游离脂肪酸通过丰富表达的白细胞介素-1 受体 I 在胰岛中引发炎症反应。
Endocrinology. 2009 Dec;150(12):5218-29. doi: 10.1210/en.2009-0543. Epub 2009 Oct 9.
9
Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.阿尔茨海默病患者血清、脑脊液及脑组织中炎症因子的纵向研究:白细胞介素-1β、白细胞介素-6、白细胞介素-1受体拮抗剂、肿瘤坏死因子-α、可溶性肿瘤坏死因子受体I和II以及α1-抗糜蛋白酶。
Alzheimer Dis Assoc Disord. 1998 Sep;12(3):215-27. doi: 10.1097/00002093-199809000-00016.
10
IFN-gamma and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes.干扰素-γ和白细胞介素-10抑制白细胞介素-4和白细胞介素-13诱导人单核细胞中I型和II型白细胞介素-1受体基因的表达。
J Immunol. 1997 Dec 15;159(12):6226-33.

引用本文的文献

1
Identification of blood plasma protein ratios for distinguishing Alzheimer's disease from healthy controls using machine learning.利用机器学习识别用于区分阿尔茨海默病与健康对照的血浆蛋白比率
Heliyon. 2025 Jan 28;11(3):e42349. doi: 10.1016/j.heliyon.2025.e42349. eCollection 2025 Feb 15.
2
Damage-mediated macrophage polarization in sterile inflammation.损伤相关的巨噬细胞极化在非感染性炎症中的作用
Front Immunol. 2023 Jul 3;14:1169560. doi: 10.3389/fimmu.2023.1169560. eCollection 2023.
3
Inflammatory Processes in Alzheimer's Disease-Pathomechanism, Diagnosis and Treatment: A Review.

本文引用的文献

1
T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers.T 淋巴细胞和炎症介质在阿尔茨海默病脑-血相互作用中的作用:新生物标志物的潜在来源。
J Immunol Res. 2017;2017:4626540. doi: 10.1155/2017/4626540. Epub 2017 Feb 15.
2
Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.阿尔茨海默病模型中小胶质细胞和单核细胞衍生巨噬细胞的不同炎症表型:衰老和淀粉样蛋白病理的影响。
Aging Cell. 2017 Feb;16(1):27-38. doi: 10.1111/acel.12522. Epub 2016 Oct 8.
3
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.
阿尔茨海默病中的炎症过程——发病机制、诊断和治疗:综述。
Int J Mol Sci. 2023 Mar 30;24(7):6518. doi: 10.3390/ijms24076518.
4
Blood Analytes as Biomarkers of Mechanisms Involved in Alzheimer's Disease Progression.血液分析物作为阿尔茨海默病进展中涉及机制的生物标志物。
Int J Mol Sci. 2022 Oct 31;23(21):13289. doi: 10.3390/ijms232113289.
5
Pharmacological Inhibition of Amyloidogenic APP Processing and Knock-Down of APP in Primary Human Macrophages Impairs the Secretion of Cytokines.药物抑制淀粉样前体蛋白(APP)的生成及敲低原代人巨噬细胞中的 APP 表达均会损害细胞因子的分泌。
Front Immunol. 2020 Sep 3;11:1967. doi: 10.3389/fimmu.2020.01967. eCollection 2020.
6
Ginsenoside Rg1 reduces &beta;‑amyloid levels by inhibiting CD&Kappa;5‑induced PPAR&gamma; phosphorylation in a neuron model of Alzheimer's disease.人参皂苷 Rg1 通过抑制阿尔茨海默病神经元模型中 CD&Kappa;5 诱导的 PPAR&gamma; 磷酸化来降低 &beta;‑淀粉样蛋白水平。
Mol Med Rep. 2020 Oct;22(4):3277-3288. doi: 10.3892/mmr.2020.11424. Epub 2020 Aug 7.
A/T/N:阿尔茨海默病生物标志物的无偏描述性分类方案。
Neurology. 2016 Aug 2;87(5):539-47. doi: 10.1212/WNL.0000000000002923. Epub 2016 Jul 1.
4
Alzheimer's disease lymphocytes: potential for biomarkers?阿尔茨海默病淋巴细胞:作为生物标志物的潜力?
Biomark Med. 2016;10(1):1-4. doi: 10.2217/bmm.15.79. Epub 2015 Dec 7.
5
Synapse-specific IL-1 receptor subunit reconfiguration augments vulnerability to IL-1β in the aged hippocampus.突触特异性白细胞介素-1受体亚基重排增加了老年海马体对白细胞介素-1β的易感性。
Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):E5078-87. doi: 10.1073/pnas.1514486112. Epub 2015 Aug 24.
6
Immune attack: the role of inflammation in Alzheimer disease.免疫攻击:炎症在阿尔茨海默病中的作用。
Nat Rev Neurosci. 2015 Jun;16(6):358-72. doi: 10.1038/nrn3880.
7
Neuroinflammation in Alzheimer's disease.阿尔茨海默病中的神经炎症
Lancet Neurol. 2015 Apr;14(4):388-405. doi: 10.1016/S1474-4422(15)70016-5.
8
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.推进阿尔茨海默病研究诊断标准:IWG-2 标准。
Lancet Neurol. 2014 Jun;13(6):614-29. doi: 10.1016/S1474-4422(14)70090-0.
9
Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.轻度认知障碍和阿尔茨海默病患者的体液细胞因子水平:比较综述
Mol Neurobiol. 2014 Oct;50(2):534-44. doi: 10.1007/s12035-014-8657-1. Epub 2014 Feb 25.
10
Biobanking of CSF: international standardization to optimize biomarker development.CSF 生物样本库:国际标准化以优化生物标志物的开发。
Clin Biochem. 2014 Mar;47(4-5):288-92. doi: 10.1016/j.clinbiochem.2013.12.024. Epub 2014 Jan 2.